| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
25,795 |
20,154 |
$1.19M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
22,670 |
16,977 |
$1.10M |
| 80053 |
Comprehensive metabolic panel |
44,414 |
28,803 |
$968K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
14,943 |
12,256 |
$760K |
| 70450 |
Computed tomography, head or brain; without contrast material |
8,400 |
6,479 |
$448K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
4,429 |
3,684 |
$418K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
8,030 |
6,372 |
$340K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
3,511 |
1,389 |
$237K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
5,990 |
1,615 |
$229K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,033 |
1,632 |
$171K |
| G0378 |
Hospital observation service, per hour |
22,791 |
8,822 |
$161K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
12,244 |
7,674 |
$154K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,513 |
1,249 |
$130K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
4,985 |
2,473 |
$125K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,194 |
1,868 |
$122K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,976 |
676 |
$115K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
4,847 |
2,516 |
$111K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
2,444 |
2,008 |
$110K |
| 80047 |
|
7,453 |
5,994 |
$92K |
| G0257 |
Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility |
1,131 |
368 |
$82K |
| 81025 |
|
7,273 |
6,222 |
$78K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,315 |
1,127 |
$76K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
2,486 |
1,988 |
$72K |
| 36415 |
Collection of venous blood by venipuncture |
24,358 |
11,472 |
$71K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
2,175 |
1,590 |
$69K |
| 84484 |
|
23,510 |
12,793 |
$68K |
| 82948 |
|
24,898 |
7,624 |
$63K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
5,421 |
3,384 |
$55K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
58,230 |
38,158 |
$55K |
| 97161 |
|
1,198 |
1,019 |
$54K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
9,046 |
6,782 |
$49K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,315 |
2,094 |
$47K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,195 |
369 |
$47K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,402 |
1,077 |
$35K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
186 |
145 |
$34K |
| 96415 |
|
665 |
369 |
$33K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
4,993 |
3,919 |
$33K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
791 |
493 |
$30K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
4,309 |
2,828 |
$29K |
| 87070 |
|
1,364 |
1,037 |
$28K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
12,723 |
8,400 |
$28K |
| C1729 |
Catheter, drainage |
222 |
82 |
$27K |
| A9270 |
Non-covered item or service |
7,618 |
2,796 |
$24K |
| 84702 |
|
1,167 |
954 |
$23K |
| 71046 |
Radiologic examination, chest; 2 views |
5,275 |
4,278 |
$23K |
| 11043 |
|
198 |
78 |
$22K |
| 71045 |
Radiologic examination, chest; single view |
17,446 |
13,460 |
$20K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,731 |
2,078 |
$19K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
25,954 |
19,368 |
$17K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
281 |
221 |
$16K |
| 97162 |
|
436 |
372 |
$16K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
4,814 |
3,656 |
$16K |
| 85610 |
|
12,136 |
8,575 |
$16K |
| 73562 |
|
1,675 |
1,298 |
$16K |
| 90791 |
Psychiatric diagnostic evaluation |
2,243 |
1,745 |
$15K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
4,893 |
3,625 |
$14K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,307 |
1,203 |
$14K |
| 97750 |
|
379 |
303 |
$13K |
| 85730 |
|
7,152 |
5,372 |
$12K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
2,945 |
2,032 |
$12K |
| 96367 |
|
667 |
311 |
$12K |
| 81003 |
|
22,534 |
18,011 |
$12K |
| 87641 |
|
2,149 |
1,666 |
$11K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
582 |
518 |
$11K |
| J7050 |
Infusion, normal saline solution, 250 cc |
4,021 |
2,171 |
$11K |
| 93971 |
|
1,192 |
1,000 |
$11K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
5,104 |
2,999 |
$10K |
| 76642 |
|
558 |
454 |
$10K |
| 97803 |
|
124 |
117 |
$10K |
| 83735 |
|
11,871 |
7,661 |
$10K |
| 77066 |
Tomosynthesis, mammo |
179 |
154 |
$10K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
3,062 |
2,359 |
$10K |
| 80074 |
|
999 |
757 |
$9K |
| 86850 |
|
2,098 |
1,592 |
$9K |
| 87631 |
|
675 |
545 |
$9K |
| 73610 |
|
531 |
429 |
$9K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,909 |
1,621 |
$9K |
| J1644 |
Injection, heparin sodium, per 1000 units |
2,904 |
1,513 |
$9K |
| 73630 |
|
934 |
772 |
$8K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
793 |
570 |
$8K |
| 73030 |
|
1,044 |
826 |
$8K |
| 87186 |
|
2,722 |
2,066 |
$8K |
| 93970 |
|
691 |
548 |
$7K |
| C1769 |
Guide wire |
1,214 |
856 |
$7K |
| 86900 |
|
2,633 |
2,066 |
$7K |
| 86901 |
|
2,634 |
2,067 |
$7K |
| 93017 |
|
307 |
256 |
$7K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
947 |
799 |
$7K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
5,676 |
4,559 |
$7K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
365 |
300 |
$7K |
| 83880 |
|
6,254 |
4,672 |
$6K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,368 |
1,889 |
$6K |
| 87077 |
|
3,129 |
2,413 |
$6K |
| 85027 |
|
7,428 |
4,351 |
$5K |
| 72110 |
|
720 |
596 |
$5K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
3,081 |
2,081 |
$5K |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
263 |
226 |
$5K |
| 87205 |
|
1,522 |
1,149 |
$5K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
252 |
213 |
$5K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
2,255 |
1,693 |
$5K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
257 |
109 |
$5K |
| J1756 |
Injection, iron sucrose, 1 mg |
548 |
199 |
$5K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
5,288 |
3,143 |
$4K |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
218 |
185 |
$4K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
444 |
237 |
$4K |
| 82330 |
|
15,375 |
12,020 |
$4K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,274 |
2,081 |
$4K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
733 |
679 |
$4K |
| 73130 |
|
363 |
304 |
$4K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
85 |
70 |
$4K |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
968 |
718 |
$4K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,674 |
2,133 |
$4K |
| 72100 |
|
443 |
314 |
$4K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
216 |
189 |
$4K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
698 |
380 |
$3K |
| 87640 |
|
1,131 |
874 |
$3K |
| 73110 |
|
179 |
148 |
$3K |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
758 |
534 |
$3K |
| 83615 |
|
641 |
446 |
$3K |
| 84145 |
|
1,755 |
1,241 |
$3K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,279 |
2,084 |
$3K |
| 82805 |
|
916 |
703 |
$3K |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
34 |
25 |
$3K |
| 97802 |
|
28 |
28 |
$3K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,402 |
2,725 |
$3K |
| 36430 |
|
68 |
42 |
$3K |
| 49083 |
|
72 |
28 |
$2K |
| 83605 |
|
2,176 |
1,700 |
$2K |
| 83690 |
|
7,175 |
5,778 |
$2K |
| 94060 |
|
46 |
40 |
$2K |
| 87040 |
|
2,158 |
1,726 |
$2K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
4,444 |
3,077 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
6,617 |
5,142 |
$2K |
| J2060 |
Injection, lorazepam, 2 mg |
3,776 |
2,551 |
$2K |
| 85018 |
|
479 |
314 |
$2K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
262 |
195 |
$2K |
| 82746 |
|
1,205 |
950 |
$2K |
| 82607 |
|
1,327 |
1,037 |
$2K |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
940 |
691 |
$2K |
| 85014 |
|
391 |
260 |
$2K |
| 84703 |
|
3,674 |
3,207 |
$2K |
| 80061 |
Lipid panel |
1,983 |
1,576 |
$2K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
14 |
12 |
$2K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
161 |
70 |
$2K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
5,662 |
2,556 |
$2K |
| J1453 |
Injection, fosaprepitant, 1 mg |
111 |
67 |
$1K |
| 73502 |
|
599 |
470 |
$1K |
| 85380 |
|
2,030 |
1,722 |
$1K |
| 87510 |
|
1,929 |
1,766 |
$1K |
| 87660 |
|
1,929 |
1,766 |
$1K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
773 |
425 |
$1K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
99 |
80 |
$1K |
| 76801 |
|
502 |
426 |
$1K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
1,022 |
723 |
$1K |
| 80164 |
|
693 |
451 |
$1K |
| 36591 |
|
148 |
62 |
$1K |
| 82077 |
|
2,046 |
1,645 |
$1K |
| 90715 |
|
580 |
461 |
$976.12 |
| 77065 |
Tomosynthesis, mammo |
42 |
37 |
$899.72 |
| 82728 |
|
707 |
557 |
$889.25 |
| 82550 |
|
2,090 |
1,493 |
$874.94 |
| 84100 |
|
992 |
679 |
$844.48 |
| 93880 |
|
64 |
50 |
$797.78 |
| J1815 |
Injection, insulin, per 5 units |
3,938 |
1,858 |
$756.44 |
| 72040 |
|
28 |
25 |
$717.59 |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
286 |
234 |
$704.70 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,333 |
1,086 |
$660.76 |
| 71101 |
|
34 |
26 |
$658.51 |
| 71250 |
|
90 |
70 |
$656.73 |
| 74018 |
|
253 |
169 |
$634.12 |
| 81001 |
|
1,416 |
1,161 |
$633.60 |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
69 |
41 |
$604.06 |
| 0100U |
|
42 |
30 |
$603.25 |
| J3490 |
Unclassified drugs |
380 |
328 |
$593.46 |
| 70486 |
|
84 |
60 |
$589.04 |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
288 |
244 |
$583.76 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
2,002 |
1,554 |
$578.22 |
| 97165 |
|
32 |
25 |
$555.96 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
264 |
215 |
$530.57 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
556 |
249 |
$512.90 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
1,557 |
1,041 |
$480.78 |
| 76830 |
Ultrasound, transvaginal |
376 |
332 |
$404.33 |
| 87075 |
|
166 |
119 |
$379.90 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
564 |
410 |
$356.51 |
| 83550 |
|
367 |
283 |
$342.88 |
| 83540 |
|
421 |
323 |
$341.95 |
| J0456 |
Injection, azithromycin, 500 mg |
130 |
84 |
$334.67 |
| 84439 |
|
454 |
355 |
$324.80 |
| 51798 |
|
116 |
76 |
$314.43 |
| 85652 |
|
1,350 |
1,071 |
$286.88 |
| 74022 |
|
213 |
175 |
$276.79 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
1,121 |
906 |
$268.64 |
| 73590 |
|
14 |
12 |
$242.34 |
| 70491 |
|
15 |
12 |
$222.33 |
| J1630 |
Injection, haloperidol, up to 5 mg |
820 |
614 |
$185.34 |
| 0240U |
|
203 |
120 |
$182.67 |
| 87480 |
|
1,941 |
1,777 |
$173.11 |
| 82140 |
|
767 |
533 |
$144.31 |
| 96523 |
|
17 |
12 |
$137.26 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
166 |
136 |
$120.91 |
| J0692 |
Injection, cefepime hydrochloride, 500 mg |
197 |
107 |
$113.93 |
| 72072 |
|
13 |
12 |
$104.54 |
| C9113 |
Injection, pantoprazole sodium, per vial |
736 |
389 |
$88.10 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
513 |
386 |
$68.51 |
| 94729 |
|
45 |
40 |
$63.71 |
| 86140 |
|
708 |
515 |
$60.59 |
| 86923 |
|
24 |
17 |
$57.19 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
114 |
62 |
$54.48 |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
13 |
12 |
$37.29 |
| 86709 |
|
147 |
128 |
$25.47 |
| 97116 |
|
61 |
31 |
$21.81 |
| 94726 |
|
18 |
16 |
$21.11 |
| 97535 |
Self-care/home management training, each 15 minutes |
47 |
30 |
$20.88 |
| 00731 |
|
50 |
43 |
$20.83 |
| 87400 |
|
40 |
34 |
$19.10 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
163 |
135 |
$8.44 |
| 80076 |
|
18 |
12 |
$7.15 |
| 82378 |
|
33 |
25 |
$6.75 |
| 96376 |
|
17 |
12 |
$0.90 |
| Q9961 |
High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml |
20 |
12 |
$0.00 |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
50 |
38 |
$0.00 |
| 82010 |
|
205 |
163 |
$0.00 |
| J1953 |
Injection, levetiracetam, 10 mg |
61 |
40 |
$0.00 |
| 87481 |
|
80 |
57 |
$0.00 |
| 96417 |
|
396 |
214 |
$0.00 |
| 72131 |
|
58 |
28 |
$0.00 |
| 0353U |
|
90 |
84 |
$0.00 |
| 85045 |
|
31 |
13 |
$0.00 |
| 29125 |
|
31 |
27 |
$0.00 |
| 36573 |
|
12 |
12 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
41 |
24 |
$0.00 |
| Q0244 |
Injection, casirivimab and imdevimab, 1200 mg |
16 |
15 |
$0.00 |
| J1790 |
Injection, droperidol, up to 5 mg |
65 |
53 |
$0.00 |
| 90686 |
|
88 |
70 |
$0.00 |
| J1940 |
Injection, furosemide, up to 20 mg |
128 |
78 |
$0.00 |
| J2785 |
Injection, regadenoson, 0.1 mg |
118 |
92 |
$0.00 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
344 |
145 |
$0.00 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
478 |
218 |
$0.00 |
| 88342 |
|
133 |
105 |
$0.00 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
89 |
71 |
$0.00 |
| 87430 |
|
34 |
31 |
$0.00 |
| 96411 |
|
211 |
123 |
$0.00 |
| 0352U |
|
41 |
41 |
$0.00 |
| J9045 |
Injection, carboplatin, 50 mg |
25 |
14 |
$0.00 |
| J3480 |
Injection, potassium chloride, per 2 meq |
40 |
27 |
$0.00 |
| 88300 |
|
18 |
12 |
$0.00 |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
39 |
27 |
$0.00 |